ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - FRA:ILU - US4523271090 - Common Stock
85.27 EUR
-0.71 (-0.83%)
Taking everything into account, ILU scores 6 out of 10 in our fundamental rating. ILU was compared to 20 industry peers in the Life Sciences Tools & Services industry. ILU gets an excellent profitability rating and is at the same time showing great financial health properties. ILU has a correct valuation and a medium growth rate. This makes ILU very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year ILU was profitable.
ILU had a positive operating cash flow in the past year.
In multiple years ILU reported negative net income over the last 5 years.
In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 20.67%, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ILU has a Return On Equity of 55.71%. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.77%, ILU belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| ROIC | 13.77% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of ILU (29.37%) is better than 100.00% of its industry peers.
ILU has a better Operating Margin (21.13%) than 94.44% of its industry peers.
In the last couple of years the Operating Margin of ILU has declined.
ILU has a Gross Margin of 67.09%. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.13% | ||
| PM (TTM) | 29.37% | ||
| GM | 67.09% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ILU is creating some value.
Compared to 1 year ago, ILU has about the same amount of shares outstanding.
Compared to 5 years ago, ILU has more shares outstanding
Compared to 1 year ago, ILU has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.64 indicates that ILU is not in any danger for bankruptcy at the moment.
The Altman-Z score of ILU (3.64) is better than 72.22% of its industry peers.
The Debt to FCF ratio of ILU is 1.93, which is an excellent value as it means it would take ILU, only 1.93 years of fcf income to pay off all of its debts.
ILU has a better Debt to FCF ratio (1.93) than 94.44% of its industry peers.
ILU has a Debt/Equity ratio of 0.66. This is a neutral value indicating ILU is somewhat dependend on debt financing.
ILU has a Debt to Equity ratio (0.66) which is in line with its industry peers.
Even though the debt/equity ratio score it not favorable for ILU, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.93 | ||
| Altman-Z | 3.64 |
ROIC/WACC1.34
WACC10.24%
2.3 Liquidity
ILU has a Current Ratio of 1.81. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.81, ILU is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
A Quick Ratio of 1.41 indicates that ILU should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.41, ILU belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 352.17% over the past year.
Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
ILU shows a decrease in Revenue. In the last year, the revenue decreased by -3.27%.
Measured over the past years, ILU shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)352.17%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%230.56%
Revenue 1Y (TTM)-3.27%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-4.77%
3.2 Future
ILU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.91% yearly.
ILU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.67% yearly.
EPS Next Y88.03%
EPS Next 2Y42%
EPS Next 3Y31.75%
EPS Next 5Y23.91%
Revenue Next Year-1.41%
Revenue Next 2Y0.64%
Revenue Next 3Y2.25%
Revenue Next 5Y3.67%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.02, ILU is valued on the expensive side.
Based on the Price/Earnings ratio, ILU is valued a bit cheaper than 61.11% of the companies in the same industry.
ILU is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 20.25, ILU is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ILU indicates a somewhat cheap valuation: ILU is cheaper than 61.11% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ILU to the average of the S&P500 Index (23.32), we can say ILU is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.02 | ||
| Fwd PE | 20.25 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ILU is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ILU indicates a rather cheap valuation: ILU is cheaper than 83.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.92 | ||
| EV/EBITDA | 13.52 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ILU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ILU's earnings are expected to grow with 31.75% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y42%
EPS Next 3Y31.75%
5. Dividend
5.1 Amount
No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (10/3/2025, 7:00:00 PM)
85.27
-0.71 (-0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.96%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap13.11B
Analysts71.72
Price Target97.79 (14.68%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.3%
Min EPS beat(2)1.33%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-7.76%
Max EPS beat(4)26.88%
EPS beat(8)6
Avg EPS beat(8)115.88%
EPS beat(12)10
Avg EPS beat(12)231.91%
EPS beat(16)13
Avg EPS beat(16)178.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.63%
Revenue beat(12)4
Avg Revenue beat(12)-0.69%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)0.41%
PT rev (3m)1.87%
EPS NQ rev (1m)0.18%
EPS NQ rev (3m)8.61%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)6.79%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.02 | ||
| Fwd PE | 20.25 | ||
| P/S | 3.59 | ||
| P/FCF | 14.92 | ||
| P/OCF | 13.33 | ||
| P/B | 6.81 | ||
| P/tB | 16.96 | ||
| EV/EBITDA | 13.52 |
EPS(TTM)3.55
EY4.16%
EPS(NY)4.21
Fwd EY4.94%
FCF(TTM)5.72
FCFY6.7%
OCF(TTM)6.4
OCFY7.5%
SpS23.75
BVpS12.52
TBVpS5.03
PEG (NY)0.27
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| ROCE | 19.56% | ||
| ROIC | 13.77% | ||
| ROICexc | 18.36% | ||
| ROICexgc | 30.05% | ||
| OM | 21.13% | ||
| PM (TTM) | 29.37% | ||
| GM | 67.09% | ||
| FCFM | 24.07% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.93 | ||
| Debt/EBITDA | 1.26 | ||
| Cap/Depr | 44.24% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.55% | ||
| Profit Quality | 81.96% | ||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 3.64 |
F-Score6
WACC10.24%
ROIC/WACC1.34
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)352.17%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%230.56%
EPS Next Y88.03%
EPS Next 2Y42%
EPS Next 3Y31.75%
EPS Next 5Y23.91%
Revenue 1Y (TTM)-3.27%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-4.77%
Revenue Next Year-1.41%
Revenue Next 2Y0.64%
Revenue Next 3Y2.25%
Revenue Next 5Y3.67%
EBIT growth 1Y275.52%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year30.85%
EBIT Next 3Y15.15%
EBIT Next 5Y14.59%
FCF growth 1Y560.27%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y449.52%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%